Skip to main content
Premium Trial:

Request an Annual Quote

Hannah Monds, David Dodd

Premium
Gene Express has  announced the appointment of Hannah Monds as its director of business development.
 
Prior to joining Gene Express, Monds spent more than 10 years with AAIPharma, a provider of product development and support services to the pharmaceutical, biotechnology, and medical device industries.
 

 
Private equity firm Genstar Capital, based in San Francisco, this week announced the formation of a strategic relationship with David Dodd to accelerate the company’s investment efforts in life sciences.
 
Dodd, former CEO of Serologicals and a pharmaceuticals/life sciences industry veteran, will work jointly with Harold “Bud” Ingalls, CFO, to source investment opportunities, the company said in a statement.

Filed under

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.